Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,800
Closed -$310K 1146
2022
Q1
$310K Buy
1,800
+112
+7% +$16.7K ﹤0.01% 989
2021
Q4
$273K Sell
1,688
-198
-10% -$31.8K ﹤0.01% 1045
2021
Q3
$281K Sell
1,886
-36,133
-95% -$7.51M ﹤0.01% 1021
2021
Q2
$9.31M Buy
38,019
+2,882
+8% +$756K 0.07% 224
2021
Q1
$9.3M Buy
35,137
+17,624
+101% +$4.97M 0.07% 210
2020
Q4
$5.14M Buy
+17,513
New +$4.49M 0.04% 301

Other funds holding AMED

Commerce Bank's AMED Position: Q2 2022 in Review

Commerce Bank sold out of Amedisys (AMED) in Q2 2022, closing a stake of 1,800 shares — an estimated $310K sold.

Commerce Bank first reported a position in AMED in Q4 2020 and held it in 6 quarters. The position peaked at $9.31M in Q2 2021. 288 funds tracked by Wall St. Rank hold AMED as of Q2 2022.

  • Commerce Bank reported no remaining Amedisys position as of Q2 2022 after selling out during the quarter.
  • Commerce Bank sold 1,800 Amedisys shares in Q2 2022, an estimated $310K.
  • Commerce Bank first reported a position in Amedisys in Q4 2020 and held it in 6 quarters.
  • Commerce Bank's Amedisys position peaked at $9.31M in Q2 2021.
  • 288 funds tracked by Wall St. Rank held Amedisys as of Q2 2022.

Based on Commerce Bank's 13F filing for Q2 2022, filed 12 Aug 2022.